Fifty patients (41 females and 9 males, ranging in age from 12 to 79 years) with systemic lupus erythematosus (SLE) and 20 normal controls were evaluated for the presence of plasma cell-free Fcγ receptor III (FcγRIII) using an ELISA based upon a sandwich of two monoclonal antibodies. The standard curve was obtained with serial dilutions of recombinant FcγRIII. In the patients, the cell-free FcγRIII levels ranged from to 1.76 μg/ml, while it did not exceed 0.21 μg/ml in the controls. Assuming that the cutoff is 0.25 μg/ml, 11 SLE patients and no controls had elevated cell-free FcγRIII levels in the serum. Among the SLE patients, the level of cell-free FcγRIII was significantly lower (p = 0.05) in 4 patients with sicca syndrome than in the remaining 46. Furthermore, cell-free FcγRIII levels appeared to be lower in 11 patients with renal involvement than in those without. For the biological parameters, we observed that the 27 patients who presented lymphopenia also had a lower level of cell-free FcγRIII when compared to the 23 patients without lymphopenia (0.09 ± 0.19 versus 0.35 ± 0.52 μg/ml; p = 0.05). Circulating cell-free FcγRIII may originate from shedding by presumably activated polymorphonuclear cells.